Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Gemcitabine in Advanced Pancreatic Cancer
NCT00005591Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 1999
- Primary completion
- Apr 2003
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of cetuximab in pancreatic cancer (PC), sponsored by University of Alabama at Birmingham. Planned start Oct 1999; status: withdrawn.
02
Drugs
cetuximab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00005591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005591.